{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:28:32Z","timestamp":1790411312098,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.trsl.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T00:46:19Z","timestamp":1365468379000},"page":"144-155","source":"Crossref","is-referenced-by-count":121,"title":["New vaccines for neglected parasitic diseases and dengue"],"prefix":"10.1016","volume":"162","author":[{"given":"Coreen M.","family":"Beaumier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia M.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2013.03.006_bib1","unstructured":"AVERT. Global HIV and AIDS estimates, 2009 and 2010. Available at: http:\/\/www.avert.org\/worldstats.htm. Accessed November 4,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib2","unstructured":"World Health Organization. Tuberculosis fact sheet 2012. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/. Accessed November 4,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2012.11-0814","article-title":"The Four Horsemen of the Apocalypse: tropical medicine in the fight against plague, death, famine, and war","volume":"87","author":"Hotez","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib4","unstructured":"A fall to cheer. The Economist 2012. Available at: http:\/\/www.economist.com\/node\/21548963. Accessed November 4,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/14760584.7.6.745","article-title":"Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis","volume":"7","author":"Hotez","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.trsl.2013.03.006_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2013.03.006_bib7","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1371\/journal.pntd.0000559","article-title":"Empowering women and improving female reproductive health through control of neglected tropical diseases","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib8","doi-asserted-by":"crossref","first-page":"e1396","DOI":"10.1371\/journal.pntd.0001396","article-title":"Examining the relationship between urogenital schistosomiasis and HIV infection","volume":"5","author":"Mbabazi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib9","unstructured":"World Health Organization. Neglected tropical diseases. 2012. Available at: http:\/\/www.who.int\/gho\/neglected_diseases\/en\/index.html. Accessed November 4,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1377\/hlthaff.2011.0317","article-title":"A handful of \u2018antipoverty\u2019 vaccines exist for neglected diseases, but the world\u2019s poorest billion people need more","volume":"30","author":"Hotez","year":"2011","journal-title":"Health Aff"},{"key":"10.1016\/j.trsl.2013.03.006_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4269\/ajtmh.1989.40.571","article-title":"Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up: Charles Franklin Craig lecture","volume":"40","author":"Gubler","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/514047","article-title":"Early clinical and laboratory indicators of acute dengue illness","volume":"176","author":"Kalayanarooj","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1473-3099(01)00171-2","article-title":"Dengue: an update","volume":"2","author":"Guzman","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib14","first-page":"577","article-title":"Locally acquired dengue: Key West, Florida, 2009\u20132010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.trsl.2013.03.006_bib15","first-page":"301","article-title":"Immune enhancement of viral infection","volume":"31","author":"Halstead","year":"1982","journal-title":"Prog Allergy"},{"key":"10.1016\/j.trsl.2013.03.006_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand: I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.trsl.2013.03.006_bib17","first-page":"96","article-title":"Hemorrhagic fever in Thailand; recent knowledge regarding etiology","volume":"20","author":"Halstead","year":"1967","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.trsl.2013.03.006_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI113911","article-title":"Human T cell responses to dengue virus antigens: proliferative responses and interferon gamma production","volume":"83","author":"Kurane","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2013.03.006_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.170.3.763","article-title":"Dengue virus-specific human T cell clones: serotype cross-reactive proliferation, interferon gamma production, and cytotoxic activity","volume":"170","author":"Kurane","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2013.03.006_bib22","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1128\/JVI.72.5.3999-4004.1998","article-title":"Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection","volume":"72","author":"Mathew","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.trsl.2013.03.006_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2013.03.006_bib24","unstructured":"National Institute of Allergy and Infectious Diseases. Evaluating the safety and immune response to two admixtures of a tetravalent dengue virus vaccine. 2012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01506570?term=Tetravax-DV&rank=3. Accessed November 4,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4161\/hv.7.6.14985","article-title":"Vaccines for the prevention of dengue: development update","volume":"7","author":"Thomas","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.trsl.2013.03.006_bib26","unstructured":"Sanofi-Pasteur. Sanofi Pasteur\u2019s dengue vaccine demonstrates proof of efficacy. 2012. Available at: 5 www.sanofipasteur.com\/articles\/1118-sanofi-pasteur\u2019s-dengue-vaccine-demonstrates-proof-of-efficacy.html. Accessed November 2,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib27","unstructured":"Inviragen. Safety and immunogenicity study to assess DENVax, a live attenuated tetravalent vaccine for prevention of dengue fever. 2011. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01224639?term=DENVax&rank=1. Accessed November 14,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib28","unstructured":"U.S. Army Medical Research and Materiel Command. A two-dose primary vaccination study of a tetravalent dengue virus purified inactivated vaccine vs. placebo in healthy adults.\u00a02012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01666652?term=dengue+PIV&rank=3. Accessed November 14,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib29","unstructured":"U.S. Army Medical Research and Materiel Command. A two-dose primary vaccination study of a tetravalent dengue virus purified inactivated vaccine vs. placebo in healthy adults (in Puerto Rico) (DPIV-002). 2012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01702857?term=dengue+PIV&rank=1. Accessed November 14,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib30","unstructured":"U.S. Army Medical Research and Materiel Command. Safety study of a vaccine (DENV-1 PIV) to prevent dengue disease. 2012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01502735?term=dengue+PIV&rank=2. Accessed November 14,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib31","unstructured":"Hawaii Biotech, Inc. Study of HBV-001 D1 in healthy adults. 2011. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00936429?term=HBV-001+D1&rank=1. Accessed November 14\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib32","unstructured":"U.S. Army Medical Research and Material Command. Evaluation of the safety and the ability of a DNA vaccine to protect against dengue disease. 2012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01502358?term=dengue+DNA+vaccine&rank=2. Accessed November 14,\u00a02012."},{"key":"10.1016\/j.trsl.2013.03.006_bib33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrmicro2438","article-title":"Developing vaccines to combat hookworm infection and intestinal schistosomiasis","volume":"8","author":"Hotez","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.trsl.2013.03.006_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4269\/ajtmh.2005.73.783","article-title":"Relationship between intensity of soil-transmitted helminth infections and anemia during pregnancy","volume":"73","author":"Larocque","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib35","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1177\/15648265030244S206","article-title":"Iron deficiency: global prevalence and consequences","volume":"24","author":"Stoltzfus","year":"2003","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.trsl.2013.03.006_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4269\/ajtmh.2007.77.88","article-title":"Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control","volume":"77","author":"Brooker","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2013.03.006_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0035-9203(95)90101-9","article-title":"Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area","volume":"89","author":"Albonico","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trsl.2013.03.006_bib39","doi-asserted-by":"crossref","first-page":"B227","DOI":"10.1016\/j.vaccine.2012.11.034","article-title":"Decade of vaccine collaboration (DoVC): Human Hookworm Vaccine Case Study","volume":"31S","author":"Hotez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2013.03.006_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fimmu.2012.00099","article-title":"Vaccine development against Leishmania donovani","volume":"3","author":"Das","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2013.03.006_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2013.03.006_bib42","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2013.03.006_bib43","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2013.03.006_bib44","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2013.03.006_bib45","doi-asserted-by":"crossref","first-page":"e1610","DOI":"10.1371\/journal.pntd.0001610","article-title":"KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi","volume":"6","author":"Gomes","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib46","unstructured":"Infectious Disease Research Institute. Safety and immunogenicity of the LEISH-F2 + MPL-SE Vaccine with SSG for patients with PKDL. 2011. http:\/\/clinicaltrials.gov\/show\/NCT00982774. Accessed on November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib47","unstructured":"Infectious Disease Research Institute. A study of the efficacy and safety of the LEISH-F2 + MPL-SE vaccine for treatment of cutaneious leishmaniasis. 2012. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01011309?term=nct01011309&rank=1. Accessed November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib48","unstructured":"Infectious Disease Research Institute. Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers. 2012. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01484548?term=phase+I+LEISH-F3+vaccine+trial+in+healthy+adult+volunteers&rank=1. Accessed: November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib49","unstructured":"Sabin Vaccine Insitute. Schistosmiasis vaccine project status. 2012. Available at: http:www.sabin.org\/programs\/schistosomiasis-vaccine\/project-status. Accessed November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.trsl.2013.03.006_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-3024.2011.01330.x","article-title":"Novel immunomic technologies for schistosome vaccine development","volume":"34","author":"McWilliam","year":"2012","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.trsl.2013.03.006_bib52","unstructured":"ClinicalTrials.gov N. Clinical trial of Bilhvax, a vaccine candidate against schistosomiasis (Bilhvax1a).\u00a0Lille: University Hospital; 2012.\u00a0Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01512277?term=clinical+trial+of+Bilhvax&rank=1. Accessed November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib53","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.4161\/hv.20966","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.trsl.2013.03.006_bib54","unstructured":"Oswaldo Cruz Foundation. Study to evaluate the sa fety of the vaccine prepared sm14 against schistosomiasis.\u00a02012. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01154049?term=study+to+evaluate+the+safety+of+the+vaccine+prepared+sm14+against&rank=1. Accessed November 14, 2012."},{"key":"10.1016\/j.trsl.2013.03.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.20966","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"Lee","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.trsl.2013.03.006_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.trsl.2013.03.006_bib57","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4161\/hv.7.11.17016","article-title":"Advances and challenges towards a vaccine against Chagas disease","volume":"7","author":"Quijano-Hernandez","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.trsl.2013.03.006_bib58","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1128\/IAI.01080-10","article-title":"Oral exposure to Trypanosoma cruzi elicits a systemic CD8(+) T cell response and protection against heterotopic challenge","volume":"79","author":"Collins","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.trsl.2013.03.006_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/IAI.00400-07","article-title":"Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi","volume":"76","author":"Zago","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.trsl.2013.03.006_bib60","series-title":"Parasitic helminths: targets, screens, drugs and vaccines","first-page":"357","article-title":"Vaccines linked to chemotherapy: a new approach to control helminth infections","author":"Lustigman","year":"2012"},{"key":"10.1016\/j.trsl.2013.03.006_bib61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1471-4922(02)02310-3","article-title":"Future directions for vaccine-related onchocerciasis research","volume":"18","author":"Nutman","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.trsl.2013.03.006_bib62","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/IAI.68.6.3491-3501.2000","article-title":"Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries","volume":"68","author":"Lizotte-Waniewski","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.trsl.2013.03.006_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1471-4922(01)02115-8","article-title":"Towards a vaccine for onchocerciasis","volume":"17","author":"Cook","year":"2001","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.trsl.2013.03.006_bib64","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2013.03.006_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052870","article-title":"A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes\u00a0following vaccination with RTS, S\/AS01E","volume":"7","author":"Ndungu","year":"2012","journal-title":"PLoS One"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524413000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524413000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T02:39:13Z","timestamp":1595644753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524413000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1931524413000790"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2013.03.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}